H35.15 Retinopathy of prematurity, stage 4

Name of the Condition

• Retinopathy of prematurity, stage 4

Summary

Retinopathy of prematurity (ROP) is a disorder affecting premature infants, characterized by abnormal blood vessel development in the retina. Stage 4 represents a severe phase where partial retinal detachment occurs, involving the macula or extrafoveal regions. This stage carries a high risk of vision loss if untreated, as the detachment can progress and compromise retinal function. The condition primarily affects infants born before full term, with severity influenced by gestational age and other clinical factors.

Causes

ROP is caused by the incomplete growth of retinal blood vessels in premature infants. The retina, which normally develops blood vessels by full-term birth, may not have fully vascularized in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth. In stage 4, the abnormal vessels and associated fibrous tissue lead to tractional retinal detachment, a key pathological feature.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In stage 4, symptoms may include abnormal eye movements, a white appearance of the pupil (leukocoria), or vision impairment as the child grows. Infants with this stage often show no visible signs initially, but progression can lead to noticeable visual abnormalities. Severe cases may present with retinal detachment, which can be detected during routine eye examinations.

Diagnosis

Diagnosis is confirmed through dilated eye examinations using indirect ophthalmoscopy, typically performed by a pediatric ophthalmologist. Imaging studies, such as optical coherence tomography (OCT), may be used to assess retinal structure and detachment extent. Staging follows standardized criteria, with stage 4 defined by partial retinal detachment involving the macula or extrafoveal areas.

Treatment Options

Treatment depends on the extent of detachment and may include laser photocoagulation, cryotherapy, or vitrectomy surgery to reattach the retina. Anti-vascular endothelial growth factor (anti-VEGF) injections are sometimes used to reduce abnormal vessel growth. Close monitoring is essential to guide intervention timing and prevent progression.

Prognosis and Follow-Up

Prognosis varies based on detachment severity and treatment response. Stage 4 ROP carries a higher risk of permanent vision loss, but early intervention can improve outcomes. Long-term follow-up is critical to monitor for amblyopia, refractive errors, or late complications like retinal detachment.

Complications

Complications may include permanent vision loss, amblyopia, strabismus, or retinal detachment progression. Severe cases can lead to blindness or structural eye abnormalities requiring ongoing management.

Lifestyle & Prevention

Prevention focuses on optimizing neonatal care, including careful oxygen management and monitoring of at-risk infants. While lifestyle modifications are limited in infants, ensuring proper prenatal care to reduce prematurity risk is beneficial.

When to Seek Professional Help

Seek immediate evaluation if signs of retinal detachment (e.g., leukocoria, abnormal eye movements) are observed. Routine screening for premature infants is essential, and any concerning changes should prompt urgent ophthalmologic assessment.

Tips for Medical Coders

Document the specific stage (stage 4) and any associated details, such as macular involvement or treatment provided. Ensure clinical documentation supports the severity and progression of the condition to justify coding. Note that stage 4 indicates partial retinal detachment, distinguishing it from earlier or more advanced stages.